InsiderClue
Insiders · Profile

Burrell Terry-Ann

Chief Financial Officer at Beam Therapeutics · Director at RECURSION PHARMACEUTICALS. Filing since 4 Jan 2021. CIK 0001786484

BEAM Beam Therapeutics Inc. Chief Financial Officer · 12 trades RXRX RECURSION PHARMACEUTICALS, INC. Director · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
BEAM Beam Therapeutics Inc.
1 Apr 2024
Chief Financial Officer
Sold on a plan
5,446
$174.93K
7.2%
RXRX RECURSION PHARMACEUTICALS, INC.
13 Jul 2023
Director
Sold at will
8,275
$104.14K
13.1%
RXRX RECURSION PHARMACEUTICALS, INC.
12 Jul 2023
Director
Sold at will
108,725
$1.31M
63.3%
BEAM Beam Therapeutics Inc.
4 Apr 2023
Chief Financial Officer
Sold on a plan
2,186
$63.60K
4.4%
BEAM Beam Therapeutics Inc.
3 Apr 2023
Chief Financial Officer
Sold on a plan
2,454
$74.38K
4.7%
BEAM Beam Therapeutics Inc.
27 Jan 2023
Chief Financial Officer
Sold, plan not stated
36,152
$1.63M
53.6%
BEAM Beam Therapeutics Inc.
26 Jan 2023
Chief Financial Officer
Sold, plan not stated
1,102
$49.76K
3.4%
BEAM Beam Therapeutics Inc.
24 Jan 2023
Chief Financial Officer
Sold, plan not stated
14,810
$666.66K
32.1%
BEAM Beam Therapeutics Inc.
23 Jan 2023
Chief Financial Officer
Sold, plan not stated
5,426
$244.29K
14.8%
BEAM Beam Therapeutics Inc.
18 Jan 2023
Chief Financial Officer
Sold, plan not stated
47,195
$2.13M
60.1%
BEAM Beam Therapeutics Inc.
31 Mar 2022
CFO
Sold, plan not stated
1,787
$105.63K
4.5%
BEAM Beam Therapeutics Inc.
30 Jun 2021
CFO
Sold, plan not stated
30,000
$3.66M
54.7%
BEAM Beam Therapeutics Inc.
28 Jun 2021
CFO
Sold, plan not stated
45,000
$4.85M
64.5%
BEAM Beam Therapeutics Inc.
4 Jan 2021
CFO
Sold, plan not stated
25,000
$2.04M
77.4%
14 decisions on file.